Close

Oppenheimer Remains Bullish on Opthea Ltd. (OPT) Following FDA Fast Track Designation

July 15, 2021 9:00 AM EDT Send to a Friend
Oppenheimer analyst Hartaj Singh reiterated an Outperform rating and $36.00 price target on Opthea Ltd. (NASDAQ: OPT) after recent Fast ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login